пятница, 8 апреля 2016 г.

Cidara Therapeutics Inc (CDTX) Downgraded by Zacks Investment Research to Hold

Cidara Therapeutics Inc (CDTX) Downgraded by Zacks Investment Research to Hold


According to Zacks, "Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives.



from Biotech News